Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
JSW LifeSciences was Austria’s largest independent contract research organization specializing in preclinical and Phase II–IV clinical drug development. It built a strong reputation as a leading CRO in central nervous system disorders through its proprietary genetically modified animal models and unique biomarker technologies. The company provided full-service support from preclinical efficacy studies—including molecular/cellular analysis—to late-stage multicenter trials across Europe. In August of 2012 it was acquired by QPS Holdings and now operates under the name QPS JSW.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on JSW LifeSciences.